(Q53660637)

17 May 2018

title

A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell, and tumor samples. (English)

1 reference

17 May 2018

1 reference

Lopez-Flores A

1

1 reference

17 May 2018

Jurado R

series ordinal

2

1 reference

17 May 2018

Garcia-Lopez P

series ordinal

3

1 reference

17 May 2018

publication date

19 August 2005

1 reference

17 May 2018

Journal of Pharmacological and Toxicological Methods

published in

1 reference

17 May 2018

volume

52

1 reference

17 May 2018

issue

3

1 reference

17 May 2018

page(s)

366-372

1 reference

17 May 2018

Determination of cisplatin and cis-diammineaquachloroplatinum(II) ion by liquid chromatography using post-column derivatization with diethyldithiocarbamate

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

Urine analysis of platinum species derived from cis-dichlorodiammineplatinum(II) by high-performance liquid chromatography following derivatization with sodium diethyldithiocarbamate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

Development of HPLC conditions for valid determination of hydrolysis products of cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

Rapid determination of platinum by flameless atomic absorption spectrophotometry following the administration of cisplatin to cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

Comparison of the pharmacokinetics of ultrafilterable cisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

Mechanisms of resistance to cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

A sensitive postcolumn derivatization/UV detection system for HPLC determination of antitumor divalent and quadrivalent platinum complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

Drugs five years later. Cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

High-performance liquid chromatographic separation of platinum complexes containing the cis-1,2-diaminocyclohexane carrier ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

Intracellular metabolites of cisplatin in the rat kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

Decomposition kinetics of cisplatin in human biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

Cisplatin: mode of cytotoxic action and molecular basis of resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.06.005

10.1016/J.VASCN.2005.06.005

7 January 2021

Identifiers

DOI

1 reference

17 May 2018

1 reference

17 May 2018